Orange Book product · Generic (ANDA)
COLESTIPOL HYDROCHLORIDE
COLESTIPOL HYDROCHLORIDE
At a glance
Mar 10, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 10, 2022
4 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
COLESTIPOL HYDROCHLORIDE
Strength
1GM
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 215223
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of COLESTIPOL HYDROCHLORIDE
- 1995COLESTIDBrand (NDA)
NDA 017563 · PFIZER
- 1994COLESTIDBrand (NDA)
NDA 020222 · PFIZER
- 2025COLESTIPOL HYDROCHLORIDEGeneric (ANDA)
ANDA 220012 · PHARMOBEDIENT
- 2024COLESTIPOL HYDROCHLORIDEGeneric (ANDA)
ANDA 217462 · RICONPHARMA LLC
- 2024COLESTIPOL HYDROCHLORIDEGeneric (ANDA)
ANDA 217667 · EDENBRIDGE PHARMS
- 2023COLESTIPOL HYDROCHLORIDEGeneric (ANDA)
ANDA 216517 · ANI PHARMS
- 2006COLESTIPOL HYDROCHLORIDEGeneric (ANDA)
ANDA 077510 · IMPAX LABS
- 2006COLESTIPOL HYDROCHLORIDEGeneric (ANDA)
ANDA 077277 · IMPAX LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
